In collaboration with NMS Labs, medical examiner and coroner offices, crime laboratories, clinical partners, and the National Institute of Justice (NIJ), the CFSRE is documenting the first reports of NPS in the United States through analysis of seized materials and/or biological fluids. These reports are generated using comprehensive analytical techniques (e.g. GC-MS, LC-QTOF-MS, NMR) and include available information about the new substances identified at the time of reporting, as well as the analytical data generated during testing. These reports are intended to assist with the rapid identification of NPS in forensic casework and related disciplines, and should not be used for confirmatory purposes alone. The data in our new drug monographs are not externally peer-reviewed, however, the data are reviewed and interpreted internally by our leading scientific staff. All identifications are required to meet minimum criteria during review (e.g. mass error <5 ppm, retention within 0.05 minutes for GC-MS or 0.35 minutes for LC-QTOF-MS, expected vs. acquired fragmentation pattern match, etc.), depending on the analyses performed and the availability of a standard reference material. Contact our program for more information about our review and reporting processes.
To join our NPS Discovery distribution list, please email npsdiscovery@cfsre.org.
CLICK HERE FOR A DOWNLOADABLE GCMS Library Database (Last updated: 01/19/2021) – Readable in Agilent MSD ChemStation
Downloadable LC-HRMS Library Database Coming Soon!